Surgery-focused hospital chain Pristyn Care managed to grow its operating scale by 44.7% and cross Rs 450 crore mark in the fiscal year ending March 2023. The company achieved this growth with an improved economics, which is in stark contrast to FY22 when its losses rose to 332%.
Before looking into its expenses pattern, let’s take a look at Pristyn Care’s revenue streams. The Tiger Global-backed firm’s operating income grew to Rs 453 crore in FY23 from Rs 313 crore in FY22, its consolidated financial statements sourced from the Registrar of Companies (RoC) show.
Financial FY23
The company follows a hybrid model where it sets up its own clinics and utilizes third-party hospital infra to provide surgeries. It claims to have over 400 doctors who give consultations on 50-plus diseases across 40 cities.
Income from healthcare services accounted for 75% of Pristyn Care’s total operating revenue which increased by 21.6% to Rs 338 crore in FY23. The rest of the income generated from the sale of medical health products and advertising services during the previous fiscal year
The company also had a non-operating income of Rs 41 crore during the preceding fiscal which took its total revenue to Rs 494 crore in FY23.
See TheKredible for the detailed revenue breakup.
Moving on to the cost side, advertising cum sales promotions marked up 25% of the total expenditure. This cost increased by 17% to Rs 220 crore in FY23. Its employee benefit cost grew 36.3% during FY23. The company cumulatively spent Rs 215 crore on professional fees to doctors and surgery costs.
The firm’s cost of material consumed, freight cum distribution, commission, legal professional fees, and other overheads pushed its overall expenditure to Rs 877 crore in FY23 as compared to Rs 616 crore in FY22.
Check TheKredible for the complete expense breakup.
Expense Breakdown
https://thekredible.com/company/pristyn-care/financials
View Full Data
https://thekredible.com/company/pristyn-care/financials
View Full Data
- Cost of material consumed
- Employee benefits
- Professional fees to doctors
- Surgery costs
- Freight and distribution
- Advertising and sales promotion
- Commissions
- Others
With a decent growth in scale, the firm kept overall costs under control which led its losses to grow at 38.27% to Rs 383 crore during FY23, significantly lesser than 332% in FY22. Its ROCE and EBITDA margin stood at -54% and -71%, respectively. On a unit level, Pristyn Care spent Rs 1.94 to earn a rupee in FY23.
FY22-FY23
| FY22 | FY23 |
| Expense/₹ of Op Revenue | ₹1.97 | ₹1.94 |
| ROCE | -26% | -54% |
| EBITDA Margin | -77% | -71% |
In December 2021 (FY22), Pristyn Care raised around $85 million from Peak XV Partners, Tiger Global and others to enter unicorn club. The firm also acquired Ratan Tata and Tiger Global-backed company Lybrate in June 2022 (FY23).
